Publications by authors named "Censhan Lin"

Claim this Profile
T
theRNA: a curated knowledgebase of functional RNA therapeutics spanning diverse modalities and disease applications.
Yifan Zhou, Yongfei Hu, Luowanyue Zhang, Tianqing Wu, Suiyang Peng, Censhan Lin

Nucleic Acids Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "DGKA interacts with SRC/FAK to promote the metastasis of non-small cell lung cancer" [Canc. Lett. (2022 Apr 28) 532 215585].
Lingyi Fu, Ru Deng, Yuhua Huang, Xia Yang, Neng Jiang, Censhan Lin

Cancer Lett· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DGKA interacts with SRC/FAK to promote the metastasis of non-small cell lung cancer.
Lingyi Fu, Ru Deng, Yuhua Huang, Xia Yang, Neng Jiang, Censhan Lin

Cancer Lett· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nucleoporin 93 mediates β-catenin nuclear import to promote hepatocellular carcinoma progression and metastasis.
Cen-Shan Lin, Yuyi Liang, Shu-Guang Su, Yin-Li Zheng, Xia Yang, Lingyi Fu

Cancer Lett· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
G3BP2 regulated by the lncRNA LINC01554 facilitates esophageal squamous cell carcinoma metastasis through stabilizing HDGF transcript.
Yinli Zheng, Jinjun Wu, Ru Deng, Censhan Lin, Yuhua Huang

Oncogene· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinicopathologic features, tumor immune microenvironment and genomic landscape of Epstein-Barr virus-associated intrahepatic cholangiocarcinoma.
Yu-Hua Huang, Chris Zhi-Yi Zhang, Qun-Sheng Huang, Joe Yeong, Fang Wang, Cen-Shan Lin

J Hepatol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tyrosine metabolic enzyme HPD is decreased and predicts unfavorable outcomes in hepatocellular carcinoma.
Xia Yang, Shi-Lu Chen, Cen-Shan Lin, Li-Li Liu, Chun-Hua Wang

Pathol Res Pract· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A GYS2/p53 Negative Feedback Loop Restricts Tumor Growth in HBV-Related Hepatocellular Carcinoma.
Shi-Lu Chen, Chris Zhiyi Zhang, Li-Li Liu, Shi-Xun Lu, Ying-Hua Pan, Cen-Shan Lin

Cancer Res· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis